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This study was conducted to elucidate the mechanism underlying the hypolipidemic action of karaya saponin or Rhodobacter
(R.) capsulatus. A total of 40 laying hens (20-week-old) were assigned into four dietary treatment groups and fed a basal diet
(as a control) or basal diets supplemented with either karaya saponin, R. capsulatus, or both for 60 days. The level of serum
low-density-lipoprotein cholesterol and the levels of cholesterol and triglycerides in the serum, liver, and egg yolk were reduced
by all the supplementations (P<. 05). Liver bile acid concentration and fecal concentrations of cholesterol, triacylglycerol, and
bile acid were simultaneously increased by the supplementation of karaya saponin, R. capsulatus, and the combination of karaya
saponinandR.capsulatus(P<. 05).Thesupplementationofkarayasaponin,R.capsulatus,andthecombinationofkarayasaponin
and R. capsulatus suppressed the incorporation of 14Cf r o m1 - 14C-palmitic acid into the fractions of total lipids, phospholipids,
triacylglycerol, and cholesterol in the liver in vitro (P<. 05). These ﬁndings suggest that the hypocholesterolemic eﬀects of karaya
saponin and R. capsulatus are caused by the suppression of the cholesterol synthesis and the promotion of cholesterol catabolism
in the liver.
1.Introduction
Saponins are natural detergent forms of a heterogeneous
group of triterpene or steroid glycosides that occur in
many hundreds of plant species [1]. A number of studies
have shown that diﬀerent kinds of saponins lower serum
cholesterol levels in a variety of animals and human subjects
[2–4]. Recently, we have reported that karaya saponin
is the best hypocholesterolemic substrate, because karaya
saponin reduced serum cholesterol concentration by 34%
in rats while tea, quillaja, or soyabean saponins resulted in
reductions of less than 20% [5]. We have also reported that
Rhodobacter capsulatus (R. capsulatus), which is a photosyn-
thetic bacterium, exhibits hypocholesterolemic activities in
laying hens (15%) [6], Japanese quails [7], rats [8], and pigs
[9]. Furthermore, we found that the combination of karaya
saponin and R. capsulatus as supplementation in a hen’s diet
causes much larger reductions in serum (32%) and egg yolk
cholesterol (18%) levels than saponin alone [10]. However,
the mechanism underlying the hypocholesterolemic eﬀect of
karaya saponin and R. capsulatus has not been clariﬁed.
Recent studies have revealed that bile acids are ligands
of several nuclear hormone receptors involved in regulating
bile acid synthesis, transport, and cholesterol metabolism.
The cholesterol pool is derived from two major sources:
the synthesis of cholesterol by the liver and the absorption
of cholesterol from the intestine [11]. The cholesterol pool
rarely changes much because cholesterol input is approxi-
mately balanced by cholesterol output via factors such as
excretion in bile/feces, skin excretion, and steroid hormone
synthesis [12]. Suppression of cholesterol synthesis is also
associated with hypocholesterolemia. Bile acid synthetic2 Cholesterol
pathway is the major pathway of cholesterol catabolism.
Zhao et al. [13] suggested that saponin lowers serum choles-
terol by increasing the conversion of cholesterol into bile
acids through the upregulation of a rate-limiting enzyme,
CYP7A1, in hepatic bile acid synthesis. Therefore, it is
possible that dietary karaya saponin and R. capsulatus exert
hypocholesterolemic activity by the suppression of hepatic
cholesterol synthesis and/or the promotion of bile acid
synthesis in laying hens.
Thus, in the present study, we investigated the eﬀect of
karaya saponin and R. capsulatus on lipid metabolism in
laying hens.
2.MaterialsandMethods
2.1. Birds, Management and Diets. A total of 40 Boris Brown
ready-to-lay pullets with almost the same live weight were
supplied by a local commercial ﬂock and reared in individual
cages (30 × 40cm). They were reared in accordance with
the “Guidelines for Regulation of Animal Experimentation,
Faculty of Agriculture, Shinshu University” and this study
was approved by an ethics committee. The birds were fed a
balanced commercial layer diet (Toyosashi Shiryo, Kabushiki
Gaisha, Aichi, Japan) and reared as previously described in
[6]. The basal diet contained (in percentages): ground yellow
corn, 56; soybean meal, 14.5; sesame meal, 7; corn gluten
meal, 2.5; rice polish, 8; ﬁsh meal, 1; calciumcarbonate, 7.68;
dicalcium phosphate, 1.32; common salt, 0.45; animal fat,
1; and vitamin premix, 0.25. The calculated [14]n u t r i e n t
composition of the basal diet was 2,935kcal/kg of ME,
16.46% CP, 2.9% Ca, 0.34% available P, 0.54% Met + Cys,
0.71% Lys, and 86µg/g of cholesterol. There is no diﬀerence
in fatty acid composition in experimental diets. Hens were
assigned into four dietary treatment groups and fed the basal
diet or basal diets supplemented with either R. capsulatus
(0.04%), karaya saponin (75mg/kgdiet), or both for a 60-
day feeding period. Karaya saponin was obtained from
Nacalai Tesque, Kyoto, Japan. R. capsulatus cells were grown
in outdoor culture under natural illumination as previously
described in [15]. The diets and water were provided ad
libitum throughout the experiment, and a photoperiod of
16L:8D was used.
2.2. Sample Preparation and Enzymatic Analysis. The laying
hens were weighed individually prior to blood collection
at the beginning and at the end of each 2-week feeding
period. Blood was collected from the brachial wing vein
using sterilized syringes and needles. After 1h standing at
room temperature, serum was isolated by centrifugation at
1150×g for 10min. Serum samples were stored at −80
◦C
until analysis. During the 60-day feeding period, feces were
collected weekly from the control and treatment groups
of laying hens. Cholesterol in the serum, egg yolk, liver,
and feces were measured spectrophotometrically (APEL Co.,
Saitama, Japan) using a commercial kit (Wako Cholesterol
E, Wako Pure Chemical Industries Ltd., Tokyo, Japan).
Triacylglycerides were measured using a commercial kit
(Wako TG, Wako Pure Chemical Industries Ltd., Tokyo,
Japan). High-density-lipoprotein (HDL) cholesterol in the
serum was determined enzymatically using a commercial
kit (Wako HDL-cholesterol, Wako Pure Chemical Industries
Ltd.). Low-density-lipoprotein (LDL) cholesterol was deter-
mined using a commercial kit (Daiichi Pure Chemicals Co.
Ltd, Tokyo, Japan) as described previously in [16]. For fecal
and hepatic bile acid determination, feces and liver samples
were ground and lyophilized, and 50mg of the lyophilized
sample was placed in a centrifuge tube containing a 1ml
mixture of t-butanol and water (1:1, v/v) [17]. The tubes
were vigorously vortexed, incubated for 20min in a gently
shaken water bath at 37
◦C and centrifuged at 1,000×gf o r
2min. The supernatant was decanted into another tube and
the bile acids were measured spectrophotometrically using a
commercial kit (Wako TBA, Wako Pure Chemical Industries
Ltd.).
2.3. Fatty Acid Determination. Total lipid extracts of yolk
samples were transmethylated into fatty acid methyl esters
and separated using a gas chromatograph (Shimadzu,
GC14B, Kyoto, Japan) and an Omegawax 250 capillary
column (30m × 0.25mm i.d.; 0.25µm thickness; Supelco,
Bellefonte, PA, USA) with cyanopropyl methyl silicone as
stationary phase. Helium was used as the carrier gas at
a constant ﬂow rate of 4.7ml/min. The following oven
temperature program was used: 100
◦C held for 1min,
increased to 160
◦Ca t4 0
◦C/min then to 240
◦Ca t7 ◦C/min,
and 240
◦C held for 10min. Peaks were separated using a
ﬂame-ionization detector and quantiﬁed with an electric
integrator (Shimadzu, CR-1A, Kyoto, Japan) using pure
standard mixtures (Sigma, St. Louis, 151 MO, USA). We
adopted the weight percentage of each fatty acid in all
detected fatty acids as a measurement value.
2.4. Incorporation of 1-14C-Palmitic Acid into Liver Tissue. At
the end of the feeding period, the laying hens were decap-
itated, and left liver lobes were collected and chilled in ice-
cold phosphate buﬀer solution (PBS). Liver lobes were sliced
into 1mm pieces, lightly pressed on sterilized paper and
weighed prior to use in incubations with 1-14C-palmitate.
About 0.5g of liver slice was placed in the tube with 990µl
of PBS and 37KBq (10µl) of 1-14C-palmitic acid (speciﬁc
activity: 1.92GBq/mmol; American Radiolabeled Chemicals
Inc., St. Louis, MO, USA). The tubes were kept closed during
the incubation period and agitated in a water-bath shaker at
39
◦C for 3 hours. At the end of the incubation, the tubes
were placed in a freezer at −40
◦C to stop the reaction. Tissue
and medium were transferred to a cup containing ﬁve times
theirvolumeofchloroform-methanol2:landhomogenized.
Thehomogenatewasﬁlteredthroughcottonﬁlterpaper.The
residue was homogenized again with ﬁve times its volume of
chloroform-methanol 2:1. This extraction step was repeated
ﬁve times and the combined extracts were centrifuged at
1,150×g for 10 min. The chloroform layer was washed with
saline solution three times in accordance with Folch et al.
[18], which removed 99% of the water-soluble radioactive
materialsandthenevaporatedtodryness.Aliquotsofhepatic
lipids were separated by thin-layer chromatography (TLC)Cholesterol 3
Table 1: Eﬀect of dietary karaya saponin and R. capsulatus on LDL, HDL, total cholesterol, triacylglycerol, and bile acids in serum, liver, and
feces of laying hens.
Parameter Treatment
Control R. capsulatus Saponin Saponin + R. capsulatus
Liver
Cholesterol (mM/g) 1.10 ±0.12a 0.59 ±0.09b 0.61 ±0.08b 0.47 ±0.04b
Triacylglycerol (mM/g) 1.65 ±0.15a 1.12 ±0.10b 1.03 ±0.04b 0.98 ±0.03b
Bile acids (nM/g) 51.9 ±3.25a 68.6 ±3.16b 70.15 ±4.22b 74.4 ±3.35b
Fecal
Cholesterol (mM/g) 0.71 ±0.05a 0.96 ±0.11b 0.98 ±0.23b 1.20 ±0.16b
Triacylglycerol (mM/g) 0.80 ±0.17a 1.20 ±0.21b 1.26 ±0.14b 1.21 ±0.12b
Bile acids (nM/g) 98.0 ±5.35a 136.6 ±6.23b 143.52 ±5.54b 158.04 ±7.15c
Serum
Cholesterol (mM/L) 3.91 ±1.18a 3.38 ±0.42b 3.16 ±0.32b 3.07 ±0.45b
Triacylglycerol (mM/L) 4.58 ±0.95a 4.26 ±1.03b 4.29 ±1.21b 4.05 ±1.63b
LDL-cholesterol (mg/dL) 112.53 ±3.44a 96.24 ±3.26ab 91.67 ±4.25b 80.16 ±3.45c
HDL-cholesterol (mg/dL) 46.25 ±2.36a 44.31 ±4.13ab 50.33 ±5.24b 58.81 ±4.37b
Yolk
Cholesterol (mM/g) 3.65 ±0.89a 3.40 ±0.74b 3.38 ±0.55b 3.19 ±0.62b
Triacylglycerol (mM/g) 23.6 ±2.16a 20.7 ±2.04b 21.71 ±3.25b 19.86 ±2.66b
a−cValues with diﬀerent superscripts diﬀer signiﬁcantly (P<. 05) in the same row; “a”, “b”, “c” indicate signiﬁcant diﬀerence from each other while “ab” is
not signiﬁcant. Values are mean ± SD for 10 laying hens per group. Diﬀerences were tested by Duncan multiple range test. HDL= High density lipoprotein;
LDL= Low density lipoprotein.
using Silica Gel G as the adsorbent and hexane-diethyl
ether-formic acid (80-20-1) as the solvent. The fractions
were detected under ultraviolet light (320nm) after spraying
the TLC plates with a methanolic solution (0.2%) of 2 7 -
dichloroﬂuorescein, and the spots were detected using the
standards for phospholipids, cholesterol, triacylglycerol, and
cholesterol esters. Spots were scraped from the plates and
collected separately in scintillation vials containing 5ml of
scintillation cocktail. The radioactivity of the samples was
then measured using a liquid scintillation counter (LS-6500;
Beckman Instruments, Fullerton, CA, USA).
2.5. Statistical Analyses. All data were analyzed by analysis
of variance using the GLM procedure of SAS (SAS Institute,
Cary, NC). Individual treatment diﬀerences were tested by
Duncan multiple-range test. Data were presented as means
± SDs. Diﬀerences were considered signiﬁcant at the level of
P<. 05.
3. Results
As shown in Table 1, dietary karaya saponin, R. capsulatus
and their combination signiﬁcantly reduced (P<. 05) the
hepatic total cholesterol and triacylglyceride levels whereas
they increase bile acid concentration (P<. 05). On the other
hand, the fecal excretions of cholesterol and triacylglycerides
were signiﬁcantly increased by karaya saponin, R. capsulatus
and their combination. The excretion of fecal bile acid was
signiﬁcantly higher for all the treatments (P<. 05). The
concentrations of total cholesterol and triacylglycerol in the
serum and egg yolk were signiﬁcantly decreased (P<. 05)
by karaya saponin, R. capsulatus and their combination.
Serum cholesterol concentration was signiﬁcantly decreased
(P<. 05) and serum HDL-cholesterol concentration was
signiﬁcantly increased (P<. 05) in the karaya saponin and
karaya saponin + R. capsulatus groups compared with those
in control group.
The eﬀects of dietary karaya saponin and R. capsulatus
on fatty acid composition in the egg yolk of laying hens
are shown in Table 2. The concentrations of oleic, linoleic
and linolenic acids in the egg yolk were signiﬁcantly
(P<. 05) increased by the karaya saponin, R. capsulatus
and karaya saponin + R. capsulatus supplemented diets as
compared with those with the control diet. Consequently,
concentrations of polyunsaturated fatty acids (PUFA) were
signiﬁcantly (P<. 05) increased in the egg yolk of karaya
saponin, R. capsulatus and karaya saponin + R. capsulatus
supplemented groups compared with those of the control
group. The ratio of PUFA to saturated fatty acids (SFA), and
PUFA and monounsaturated fatty acids (MUFA) to SFA, in
the egg yolk of the karaya saponin and karaya saponin + R.
capsulatus groups were signiﬁcantly higher (P<. 05) than
those in the control group.
The eﬀects of dietary karaya saponin and R. capsulatus
on the incorporation of 1-14C-palmitic acid into hepatic
lipids of laying hens are shown in Figure 1.T h e r ew a sa
signiﬁcantly lower (P<. 05) incorporation of 14C into
hepatic total lipids, triacylglycerides, and total cholesterol
of hens in the karaya saponin, R. capsulatus and karaya4 Cholesterol
Table 2: Eﬀect of dietary karaya saponin and R. capsulatus on yolk fatty acids.
Fatty acid Treatment
Control R. capsulatus Saponin Saponin + R. capsulatus
16:0 5.90 ±0.48a 6.78 ±0.99ab 5.83 ± 0.52ab 4.08 ±0.65b
18:0 2.01 ± 0.19 2.81 ±0.28 1.93 ±0.17 1.85 ±0.15
16:1 0.71 ± 0.07 1.08 ±0.16 1.13 ±0.20 1.11 ±0.09
18:1 7.46 ±0.88a 12.36 ±1.14b 10.75 ±1.84b 14.10 ±1.65c
18:2 11.87 ±0.97a 16.34 ±1.97b 18.25 ±2.01b 17.44 ±1.88b
18:3 2.67 ±0.17a 4.16 ±0.53b 4.33 ±0.62b 5.01 ±0.41b
MUFA 8.10 ±0.47a 12.89 ±1.16b 11.75 ±1.13ab 14.78 ±1.23c
PUFA 14.47 ±1.05a 20.50 ±0.86b 22.16 ±1.57b 22.08 ±2.11b
SFA 7.89 ± 0.82 9.59 ±0.54 7.48 ±0.43 5.77 ±0.22
PUFA : SFA 1.81 ±0.09a 2.14 ±0.08ab 2.91 ±0.05b 3.80 ±0.25b
(PUFA+MUFA):SFA 2.82 ±0.11a 3.25 ±0.24ab 4.50 ±0.31b 6.12 ±0.35b
a−cValues with diﬀerent superscripts diﬀer signiﬁcantly (P<. 05) in the same row; “a”, “b”, “c” indicate signiﬁcant diﬀerence from each other while “ab” is
not signiﬁcant. Values are means ±SD (mg/g) for 10 laying hens per group.
DiﬀerencesweretestedbyDuncanmultiplerangetest.MUFA=monounsaturatedfattyacids,PUSA=polyunsaturat edfattyacids,SF A =saturatedfattyacids.
saponin + R. capsulatus supplemented groups than that in
the control group. There was no signiﬁcant diﬀerence in the
incorporation of 14C from palmitic acid into the cholesterol
ester fraction between groups. In the phospholipid fraction,
all the treatments signiﬁcantly reduced incorporation, and
the trends of R. capsulatus and saponin + R. capsulatus
treatments were similar.
4. Discussion
The present study expands our understanding of the
cholesterol-lowering eﬀects of karaya saponin and R. capsu-
latus in laying hens. In this study, we found that the fecal
excretion of bile acids in the laying hens was signiﬁcantly
increased by karaya saponin, R. capsulatus or karaya saponin
+ R. capsulatus supplemented diet compared with that with
the control diet. Similarly, liver bile acid was also increased
by all the treatments. In both feces and liver, the trends for
bile acid were similar and the highest bile acid concentration
was found when karaya saponin and R. capsulatus,w e r e
used in combination. This indicates that these two natural
ingredients can function synergistically, at least in laying
hens. These results are in agreement with our previous
observations described in Afrose et al. [10] and Salma et
al. [6]. Many pathways and factors have been reported to
contribute to the hypocholesterolemic eﬀects of diﬀerent
dietary saponins. Cholesterol reduction by karaya saponin
and R. capsulatus is a new approach that continues to
stimulate much research and discussion. Plant saponins
exhibit many of the characteristics desirable for long-term
hyperlipidemic therapy and thus may represent a novel form
of therapy for the treatment of hypercholesterolemia [19].
In spite of the fact that a great variety of investigations
on the biological activities of saponins have been carried
out [20], studies on their eﬀects on bile acid, as described
here, are rare, aside from a number with steroid saponins.
In this study, the consequent increase in fecal excretion
is compensated for by enhanced hepatic conversion of
cholesterol to bile acid. Support of this ﬁnding comes
from an observation by Oakenfull and Fenwick [21] that
plant ﬁber preparations containing saponins bind to bile
acids in vitro. Oakenfull et al. [22] further concluded that
1% soyasaponins signiﬁcantly increase fecal bile acid and
neutralsterolexcretioncomparedwithacontroldietwithout
soyasaponin. From this study, it was also observed that
cholesterol reduction and fecal cholesterol excretion are
inversely correlated with similar magnitudes. Thus, it is
conceivable from this study that the cholesterol-lowering
eﬀect of saponin might be due to the increase in bile acid
excretion [23] that occurs through interference with the
absorption of cholesterol [24]. Potter [25] also indicated
that saponin might alter the absorption of cholesterol and
bile acid. One of the possible mechanisms for this eﬀect is
that saponin forms micelles with bile acid [26]. It has been
postulated that a saponin from platycodins may interrupt
the formation of cholesterol micelles by cocrystallizing with
cholesterol [27]. Lin et al. [28] also pointed out that saponin
binds a certain amount of bile acid when added to a diet in
rats.
The resulting decrease in cholesterol synthesis, which
was observed in laying hens that were administered feed
with karaya saponin and R. capsulatus, leads to hypocholes-
terolemia. The determination of the incorporation of labeled
palmitic acid into total lipids and the various lipid fractions
provides an indication of the pattern of lipid synthesis
inﬂuenced by the combination of karaya saponin and R. cap-
sulatus supplementation. However, our study indicates that
the classes of liver lipid were not all aﬀected by saponin or
R. capsulatus in the same manner and magnitude. Decreased
hepatic synthesis of cholesterol from precursor palmitic acid
from the saponin or R. capsulatus supplemented diet is the
most detectable hypocholesterolemic eﬀect. Although the
suppression of individual cholesterol synthesis was similarCholesterol 5
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Figure 1: Eﬀect of dietary karaya saponin and R. capsulatus on the incorporation of 1-14C-palmitic acid into hepatic (a) total lipids, (b)
triacylglycerol, (c) cholesterol, (d) phospholipids, and (e) cholesterol ester fraction. Diﬀerences were tested by Duncan multiple-range test.
a−cValues with diﬀerent superscripts diﬀer signiﬁcantly (P<. 05); “a”, “b”, “c” indicate signiﬁcant diﬀerence from each other. Values are
mean ±SD, n = 10 laying hens.
for individual saponin or R. capsulatus, the combination of
these two caused a marked decrease. Thus, the synergistic
eﬀect of karaya saponin and R. capsulatus on the suppression
of cholesterogenesis is in agreement with the low hepatic
cholesterol concentration (as shown in Table 1). It was
suggested that by virtue of their purported intestinal action,
saponins could provide a nonsystemic alternative to the
commonly used HMG-CoA reductase inhibitors [29]. It is
possible that karaya saponin together with R. capsulatus
suppresses cholesterol synthesis by reducing HMG-CoA
activity. When palmitic acid is used as a substrate for lipid
synthesis under in vitro conditions, dietary saponin and R.
capsulatus could tend to reduce palmitic acid incorporation
into some lipid classes by causing a reduction in malonyl-
CoA formation. This suppression of cholesterol synthesis is
in line with our previous observations in chickens [6, 10].
The pattern of palmitic acid distribution in the various lipid
fractions of liver was diﬀerent between the treatment group
and the control. Synthesis of triacylglycerol predominates
in the chicken liver, while karaya saponin and R. capsulatus
markedly reduced this synthesis. When karaya saponin with
R. capsulatus was fed to hens, there was an approximately6 Cholesterol
25% reduction in cholesterol synthesis. Thus, the suppressed
esteriﬁcation of 1-14C-palmitic acid into triacylglycerol and
cholesterol is one of the potential hypocholesterolemic
mechanisms of karaya saponin and R. capsulatus in laying
hens.
Simultaneously, the excretion of cholesterol through
feces was also enhanced by the combined supplementation
of karaya saponin and R. capsulatus. T h ee v i d e n c ef r o m
this study suggests that this aspect of cholesterol traﬃcking
is not the cause of cholesterol modulation. Using a single
cholesterol tracer method, previously validated against the
dual isotope ratio methodology, Southon et al. [2]h a v e
shown that cholesterol absorption increased in the animals
receiving a high dose of saponin. Cholesterol excretion
and hepato-biliary-intestinal eﬄux of cholesterol appear to
be the mechanisms responsible for the lower circulating
levels. However, our data suggest that karaya saponin
acting synergistically with R. capsulatus likely increased fecal
cholesterol excretion as fecal cholesterol concentration was
increased 2-fold. In a recent study, it was observed that
saponin enhanced intestinal sterol permeability, resulting in
increased cholesterol absorption; on the other hand, there
are still certain unknown mechanisms that exist that can
enhance cholesterol eﬄux, resulting in a net depletion of the
sterol pool [13]. It is conceivable from our study that hepatic
increased bile acid resulted in fecal cholesterol excretion. The
concentration of excreted cholesterol was 35% higher in the
laying hens fed both the karaya saponin and R. capsulatus
supplemented diet than in those fed the control diet.
I nt h i ss t u d y ,s o m ef a t t ya c i d si ne g gy o l kw e r ea l t e r e d
by the karaya saponin and R. capsulatus supplementation.
We previously reported that dietary supplementation of R.
capsulatus altered the fatty acid composition of serum lipid
in rats [5]. In the present study, the combination of dietary
saponin and R. capsulatus resulted in a signiﬁcant increase
in the oleic, linoleic, and linolenic acid concentrations in
egg yolk. In broiler chickens, Salma et al. [7]r e p o r t e d
that the concentrations of oleic, linoleic, and linolenic acids
in breast and thigh meat are markedly increased by the
combined supplementation in chickens. Our ﬁndings clearly
demonstrate that dietary R. capsulatus can improve the fatty
acid composition in eggs. Although the levels of saturated
palmitic and stearic acids were slightly increased by the R.
capsulatus supplementation, they were markedly decreased
when the combination of saponin and R. capsulatus was
introduced to the diet. The alteration of the egg yolk fatty
acid proﬁle by saponin and R. capsulatus supplementation
might provide health beneﬁts. Despite the fatty acid alter-
ation eﬀects, nothing is known about the mode of action and
mechanism by which karaya saponin enhances PUFA. Thus,
it will be interesting to elucidate the mechanism underlying
this phenomenon.
Although it is diﬃcult to completely characterize the
mechanism of the action of karaya saponin, counterac-
tion of bile activity might explain the reduced cholesterol
bioaccessibility observed when karaya saponin is introduced
into the diet. The mechanism of karaya saponin and R.
capsulatus hypolipidemic action might also involve the
posttranscriptional suppression of HMG-CoA reductase in a
manner mimicking the action of putative nonsterol feedback
inhibitors. Further studies are needed to conﬁrm these
eﬀects. In conclusion, karaya saponin and R. capsulatus sup-
plementation feeding resulted in a pronounced cholesterol-
lowering eﬀect. Our study suggests that the reductions in
the levels of serum and egg cholesterol are caused by the
suppression of cholesterol synthesis and the promotion of
cholesterol catabolism in the liver.
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